David J. Bowen, Wildwood, MO (US); Catherine A. Chay, Ballwin, MO (US); Todd A. Ciche, Glencoe, MO (US); Uma R. Kesanapalli, Chesterfield, MO (US); and Jennifer L Lutke, Ballwin, MO (US)
Assigned to MONSANTO TECHNOLOGY, LLC, St. Louis, MO (US)
Filed by Monsanto Technology LLC, St. Louis, MO (US)
Filed on Jan. 6, 2023, as Appl. No. 18/151,119.
Application 18/151,119 is a continuation of application No. 17/242,049, filed on Apr. 27, 2021, granted, now 11,591,612.
Application 17/242,049 is a continuation of application No. 16/179,385, filed on Nov. 2, 2018, granted, now 11,021,715, issued on Jun. 1, 2021.
Application 16/179,385 is a continuation of application No. 15/247,500, filed on Aug. 25, 2016, granted, now 10,155,960, issued on Dec. 18, 2018.
Claims priority of provisional application 62/210,737, filed on Aug. 27, 2015.
Prior Publication US 2023/0227842 A1, Jul. 20, 2023
1. A recombinant nucleic acid molecule comprising a heterologous promoter operably linked to a polynucleotide segment encoding a protein wherein said protein comprises an amino acid sequence having the amino acid sequence as set forth in SEQ ID NO:4.